Results 1 to 10 of about 213,106 (383)

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD [PDF]

open access: yesIndian Pacing and Electrophysiology Journal
Aims: Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study was to compare urinary NT-proBNP to plasma NT-proBNP in a
Benedikt Seither   +14 more
doaj   +4 more sources

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension [PDF]

open access: yesESC Heart Failure
Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH.
Oliver Dörr   +15 more
doaj   +3 more sources

Body mass index modifies the major adverse cardiovascular and cerebral events risk of NT-proBNP in patients with acute coronary syndrome [PDF]

open access: yesDiabetology & Metabolic Syndrome
Background Little is known about the relationship between body mass index (BMI) and the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute coronary syndrome (ACS).
Xiaoquan He   +5 more
doaj   +2 more sources

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease [PDF]

open access: yesInternational Journal of Cardiology: Heart & Vasculature
Background: Atrial fibrillation (AF) screening should be considered in elderly patients with high risk of stroke, which include individuals with hypertension.
Gina Sado   +5 more
doaj   +2 more sources

Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease [PDF]

open access: yesPerioperative Medicine
Objective We aimed to probe the clinical value of N-terminus pro-brain natriuretic peptide (NT-proBNP), myeloperoxidase (MPO), and neutrophil lymphocyte ratio (NLR) combined with echocardiography in the prediction of malignant arrhythmias (MA) in elderly
Jianping Liu   +4 more
doaj   +2 more sources

Sendaway capillary NT-proBNP in pulmonary hypertension. [PDF]

open access: yesBMJ Open Respir Res
BackgroundN-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to perform NT-proBNP tests remotely.
Stubbs HD   +14 more
europepmc   +5 more sources

Machine learning integration of multimodal data identifies key features of circulating NT-proBNP in people without cardiovascular diseases [PDF]

open access: yesScientific Reports
N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) is important for diagnosing and predicting heart failure or many other diseases. However, few studies have comprehensively assessed the factors correlated with NT-proBNP levels in people with ...
Zhiyuan Ning   +7 more
doaj   +2 more sources

Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC

open access: yesEuropean Journal of Heart Failure, 2023
Diagnosing heart failure is often difficult due to the non‐specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure.
Antoni Bayés-Genís   +20 more
semanticscholar   +1 more source

NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial.

open access: yesEuropean Heart Journal, 2023
BACKGROUND AND AIMS STRONG-HF showed that rapid up-titration of guideline-recommended medical therapy (GRMT), in a high intensity care (HIC) strategy, was associated with better outcomes compared to usual care (UC).
M. Adamo   +28 more
semanticscholar   +1 more source

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance There is limited evidence on the benefits of sacubitril/valsartan vs broader renin angiotensin system inhibitor background therapy on surrogate outcome markers, 6-minute walk distance, and quality of life in patients with heart failure and ...
B. Pieske   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy